Literature DB >> 1682559

Clindamycin for toxoplasma encephalitis in AIDS.

J S Remington, J L Vildé.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682559     DOI: 10.1016/0140-6736(91)91997-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats.

Authors:  M G Davidson; M R Lappin; J R Rottman; M B Tompkins; R V English; A T Bruce; J Jayawickrama
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Plasma pyrimethamine concentrations during long-term treatment for cerebral toxoplasmosis in patients with AIDS.

Authors:  H Klinker; P Langmann; E Richter
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

Review 3.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

4.  Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS.

Authors:  A Antinori; A Ammassari; G Maiuro; G Camilli; F Damiano; G Federico; E Pizzigallo; E Tamburrini
Journal:  Ital J Neurol Sci       Date:  1992-09

5.  Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS.

Authors:  J Saba; P Morlat; F Raffi; V Hazebroucq; V Joly; C Leport; J L Vildé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-11       Impact factor: 3.267

Review 6.  Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice.

Authors:  Ildiko Rita Dunay; Kiran Gajurel; Reshika Dhakal; Oliver Liesenfeld; Jose G Montoya
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.